140 related articles for article (PubMed ID: 12425202)
1. [Efficacy and tolerance of rilmenidine in patients with mild to moderate hypertension. Results of a Czech and Slovak 6-month multicenter study].
Widimský J
Vnitr Lek; 2002 Aug; 48(8):724-9. PubMed ID: 12425202
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the antihypertensive efficacy and tolerability of fixed very low-dose perindopril/indapamid combination in patients with mild to moderate hypertension. Results of a Czech and Slovak multicentric study].
Widimský J; Fedelesová V
Vnitr Lek; 2004 Jun; 50(6):447-52. PubMed ID: 15346638
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
Widimský J; Sirotiaková J
Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
[TBL] [Abstract][Full Text] [Related]
4. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rilmenidine, a selective imidazoline I1 receptor binding ligand, in mild-to-moderate Thai hypertensive patients.
Buranakitjaroen P; Kittipawong P; Koanantakul B; Piamsomboon C; Prasassarakich N; Silaraks S; Sukonthasarn A; Tiyapant A;
J Med Assoc Thai; 2003 Oct; 86(10):903-10. PubMed ID: 14650701
[TBL] [Abstract][Full Text] [Related]
6. Update on rilmenidine: clinical benefits.
Reid JL
Am J Hypertens; 2001 Nov; 14(11 Pt 2):322S-324S. PubMed ID: 11721891
[TBL] [Abstract][Full Text] [Related]
7. Rilmenidine--its antihypertensive efficacy, safety and impact on quality of life in perimenopausal women with mild to moderate essential hypertension.
Kawecka-Jaszcz K; Czarnecka D; Klocek M; Zabojszcz M; Kucharska M; Jaworski R; Pachocki R
Blood Press; 2006; 15(1):51-8. PubMed ID: 16492616
[TBL] [Abstract][Full Text] [Related]
8. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
Scemama M; Février B; Beucler I; Dairou F
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
[TBL] [Abstract][Full Text] [Related]
9. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
[TBL] [Abstract][Full Text] [Related]
10. The chronic effect of rilmenidine on heart rate variability in patients with mild hypertension.
Eryonucu B; Ulgen MS; Bilge M; Güler N; Güneş A
Angiology; 2002; 53(2):199-204. PubMed ID: 11952111
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of long-term rilmenidine treatment in hypertensive diabetic patients. A retrospective analysis of a general practice study.
Meredith PA; Reid JL
Am J Cardiovasc Drugs; 2004; 4(3):195-200. PubMed ID: 15134471
[TBL] [Abstract][Full Text] [Related]
12. Effects of rilmenidine on 24-h rhythmicity of blood pressure and spontaneous baroreflex sensitivity in essential hypertensive subjects.
Finta E; Laude D; Alföldi S; Farsang C; Elghozi JL
J Hypertens; 2006 Aug; 24(8):1619-25. PubMed ID: 16877965
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive efficacy and acceptability of rilmenidine in elderly hypertensive patients.
Galley P; Manciet G; Hessel JL; Michel JP
Am J Cardiol; 1988 Feb; 61(7):86D-90D. PubMed ID: 2894166
[TBL] [Abstract][Full Text] [Related]
14. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rilmenidine for arterial hypertension.
Beau B; Mahieux F; Paraire M; Laurin S; Brisgand B; Vitou P
Am J Cardiol; 1988 Feb; 61(7):95D-102D. PubMed ID: 2894168
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
Panfilov V; Morris AD; Donnelly R; Reid JL
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and acceptability of rilmenidine for mild to moderate systemic hypertension.
Ostermann G; Brisgand B; Schmitt J; Fillastre JP
Am J Cardiol; 1988 Feb; 61(7):76D-80D. PubMed ID: 2894164
[TBL] [Abstract][Full Text] [Related]
18. Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.
Anichkov DA; Shostak NA; Schastnaya OV
Curr Med Res Opin; 2005 Jan; 21(1):113-9. PubMed ID: 15881482
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency.
Lins RL; Daelemans R; Dratwa M; Verbeelen D; Sennesael J; Brisgand B; Lameire N
Am J Med; 1989 Sep; 87(3C):41S-45S. PubMed ID: 2782326
[TBL] [Abstract][Full Text] [Related]
20. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
Scemama M; Février B; Beucler I; Dairou F
Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]